TTM and Ophir: Compare the Earnings Years Before the Deal Multiples

Two prices are not being quoted for the same earnings year

TTM Technologies' proposed purchase of Ophir Optics presents a useful research problem: how should an investor evaluate an acquisition when the buyer and seller describe its valuation using different earnings years? The answer begins with the denominator. A lower multiple attached to a later forecast does not, by itself, show that the buyer negotiated a cheaper deal or that the seller reported an inconsistent price.

On October 19, TTM announced an approximately $650 million cash acquisition from MKS, subject to closing adjustments. TTM described roughly 10.3 times expected fiscal 2027 adjusted EBITDA, excluding synergies. MKS described over 18 times projected fiscal 2026 adjusted EBITDA. Both statements concern the announced transaction, but their forecast periods differ. Neither denominator represents already realized earnings at closing.

Our interpretation is that the investment case requires two separate tests. First, can the acquired business deliver the earnings embedded in the later-year valuation? Second, can TTM finance the acquisition alongside its other investment plans while retaining enough liquidity? An attractive strategic fit could support the transaction, but it cannot substitute for those tests. This article examines the evidence available before the deal closes rather than predicting whether the shares will rise.

Start with a denominator worksheet

A practical worksheet should place the purchase price in one column and each forecast year, earnings definition and adjustment in separate columns. Label an estimate as an estimate at every step. Here, the same headline consideration divided by different annual earnings forecasts can naturally produce different multiples. The first analytical task is to establish comparable inputs before ranking the outputs.

Using $650 million and 10.3 solely as rounded inputs produces an illustrative implied 2027 adjusted EBITDA of approximately $63.1 million. Dividing $650 million by 18 produces approximately $36.1 million. Because the seller says over 18 times, a mechanically inferred 2026 denominator would be below that second amount if the same numerator and valuation conventions applied. These are reverse calculations from rounded announcements, not separately disclosed forecasts.

Do not turn those calculations into a precise growth target. Differences in scope, adjustments, valuation conventions or rounding can affect the comparison. The public headlines alone do not provide a complete bridge between the forecasts. A responsible model would identify the missing bridge explicitly and request comparable definitions and annual operating assumptions. It would not quietly assume that every dollar of the implied increase comes from organic demand.

The distinction changes how the deal should be monitored. Evidence that narrows the forecast bridge is more valuable than simply repeating either multiple. Useful disclosures would explain production volumes, pricing, product mix, margins and the timing of customer programs. A revised forecast could change the apparent multiple even if the purchase price remained unchanged. That is why the research should preserve both the original estimate and subsequent revisions.

Keep the acquired business boundary visible

The transaction covers Ophir Optics, which supplies infrared thermal imaging and laser optics. Both announcements exclude the separate Ophir Instruments business and the Ophir brand. Investors should therefore avoid importing the financial characteristics or customer relationships of everything carrying the Ophir name into the acquisition model. Shared branding is not proof of a shared transaction perimeter.

For valuation work, the business boundary affects more than revenue. A standalone operation can require corporate support, working capital, systems, facilities and other resources that were previously supplied within a larger group. The announcements do not quantify every separation dependency. Those items should remain questions for diligence, not invented costs or assumed savings. A forecast can look different depending on what support expenses are included.

A useful follow-up disclosure would make clear what assets, people, liabilities and transitional services accompany the business. The investor can then compare the acquired operating capability with the cash consideration and future spending requirements. Until that information is available, claims about the value of the entire brand or the economics of excluded instruments would overstate what the announced purchase actually includes.

Assess the funding plan across both investments

TTM says the acquisition and its previously announced $400 million Asian capital and capacity expansion are expected to use cash on hand, future cash flow and borrowings under its existing revolving facility. Adding the two headline amounts gives $1.05 billion. That sum is a useful scale comparison, not a forecast of a single closing-day payment: acquisition consideration and capital spending can follow different schedules.

The second-quarter release provides a dated starting point. At June 29, TTM reported about $507.9 million of cash. It also reported $96.4 million of operating cash flow for the quarter. Those amounts are historical balances and flows; neither establishes the cash available when the proposed acquisition closes. Operating cash flow also precedes capital expenditures and other uses, so treating it as wholly available acquisition funding would be misleading.

Build the funding analysis by period. Start with the latest disclosed cash, add a clearly labeled operating cash scenario, then subtract planned capital spending, other commitments and a minimum operating liquidity reserve. Any remaining requirement becomes a scenario for borrowing rather than an assertion about the eventual debt draw. This method makes the trade-offs visible without pretending that the company has already specified its final financing mix.

A simple hypothetical stress test illustrates the mechanism. If $100 million of expected internally generated cash failed to arrive before a scheduled payment, the company would need $100 million more from another source, a spending adjustment or a timing change. At an assumed annual borrowing rate of 6%, a full-year $100 million draw would imply $6 million of interest before tax. The rate, duration and draw are illustrative assumptions, not TTM guidance or current lending terms.

Do not confuse a facility limit with available liquidity

In its second-quarter release, TTM discussed a $1 billion revolver and an increased term loan as steps to improve financing flexibility. A facility's announced size is not the same as the amount still available on a later date. Outstanding borrowings, letters of credit, conditions and subsequent uses can affect what remains. The current acquisition announcement does not provide a complete closing-date liquidity schedule.

For that reason, a model should distinguish total commitment, drawn balance, available capacity and covenant headroom. These are related quantities, but substituting one for another creates false precision. The historical balance sheet is a reference point for questions; it is not a substitute for an updated borrowing disclosure. Subsequent quarterly filings and transaction financing details should replace provisional assumptions as they become available.

The favorable case is that cash generation and a staged spending schedule reduce the need to borrow at an inconvenient time. The unfavorable case is that slower collections, higher investment needs or delays compress the same liquidity cushion. Neither case follows automatically from a large financing facility. The decision-relevant evidence is how cash requirements overlap, and how much flexibility remains under the actual terms.

Separate earnings accretion from the return on cash invested

TTM expects the transaction to increase adjusted EBITDA margin and non-GAAP diluted earnings per share immediately. That is management's forward-looking expectation. It does not establish the eventual GAAP earnings contribution, cash return or payback period. A higher adjusted margin can coexist with substantial cash spending, financing expense and integration demands.

The investor should therefore retain several views of the deal. One examines the acquired business's operating performance. Another follows cash available after necessary investment. A third traces the effect of financing and accounting adjustments on earnings per share. The same transaction can look stronger under one measure than another. None should disappear merely because the acquisition announcement emphasizes a favorable metric.

Consider an explicitly hypothetical comparison: two businesses each produce $10 million of operating earnings, but one requires $2 million of recurring investment while the other requires $7 million. Before other cash adjustments, the amounts remaining differ by $5 million. This is not an estimate for Ophir. It shows why an earnings-based multiple needs a separate investment and cash-conversion assessment before it can support a shareholder-return conclusion.

What would strengthen or weaken the thesis

The announced closing target is the second quarter of 2027, subject to conditions and approvals. Until closing, the acquisition remains proposed. A research update should track regulatory and governmental milestones, changes to consideration, financing disclosures and any revision to the expected timetable. It should distinguish an announced agreement from ownership and consolidated results.

The case would strengthen if comparable disclosures explain the move from the 2026 earnings basis to the 2027 basis, operating evidence supports that bridge, and updated liquidity information shows capacity for both acquisition and expansion spending. The case would weaken if the earnings bridge depends on unsubstantiated assumptions, cash conversion falls short or financing requirements materially exceed the working scenario.

There is no need to force a definitive valuation verdict from the current headlines. The useful conclusion is narrower: the different multiples identify different forecast bases, and the funding plan spans more than one investment. Keeping those facts separate gives investors a concrete checklist for the next disclosure. It also prevents a seemingly inexpensive forward multiple from doing analytical work that only operating results and cash-flow evidence can complete.